Explore Stanford technologies available for licensing:

Stanford researchers have developed an innovative, integrated diagnostic and therapeutic focused ultrasound (FUS) platform that non-invasively targets peripheral nerves to produce temporary, reversible nerve blockade for acute and chronic pain management.

In light of the opioid epidemic within the United States, Dr. Eric Gross and colleagues developed a non-opioid therapeutic that reduces pain (Stanford Medicine Press Release).

Researchers at Stanford University and Washington University in St. Louis have discovered a novel molecular pathway for the treatment of opioid overdose.

Stanford scientists have developed a working model that chemotherapy drugs induce peripheral neuropathy by activating a pathway that favors neuronal degeneration and impairs sensory neuron function.

Stanford researchers have developed a method for targeted focused ultrasound application to peripheral nerves to suppress acute pain. This invention can non-invasively concentrate ultrasound waves onto peripheral nerves without impacting surrounding tissue.

Researchers at Stanford have synthesized a potential novel class of pain relief drugs.

Researchers at Stanford have discovered long sought after light gated potassium selective channelrhodopsins., HcKCR1 and HcKCR2.

Stanford researchers have developed method for targeted application focused ultrasound to peripheral nerves to suppress acute pain.

Researchers at Stanford have developed non-opiate methods for treating chronic pain and for retrograde transduction of neurons.

The Problem: Chronic pain is best treated with a 'whole-person' approach that include behavioral/psychological approaches to pain self-management.

Stanford researchers in the Deisseroth Lab have discovered molecular targets and brain-circuit dynamics underlying dissociation in the brain.

Title: System and methods for optogenetic stimulation and inhibition of pain

Inventors: Shrivats Iyer, Kate Montgomery, Chris Towne, Karl Deisseroth, Scott Delp.